Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -22.53% is 144% below its 5-year average of -9.24%, near the low end of its 5-year range (-24.44%–9.86%).
28.96% below its 12-month average of -17.47%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -3.00%.
RETURN ON ASSETS (ROA)
-22.53%
RETURN ON ASSETS (ROA) AVG TTM
-17.47%
RETURN ON ASSETS (ROA) AVG 3Y
-13.86%
RETURN ON ASSETS (ROA) AVG 5Y
-9.24%
RETURN ON ASSETS (ROA) AVG 10Y
-7.20%
RETURN ON ASSETS (ROA) AVG 15Y
-8.61%
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
-28.96%
CURRENT VS 3Y AVG
-62.58%
CURRENT VS 5Y AVG
-143.88%
CURRENT VS 10Y AVG
-213.07%
CURRENT VS 15Y AVG
-161.55%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-32.27%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
+30.17%
vs the sector median at left
Xencor, Inc.
Market Cap
$1.81B
Return on Assets (ROA)
-22.53%
TTM Avg
-17.47%
3Y Avg
-13.86%
5Y Avg
-9.24%
Market Cap
$1.81B
Return on Assets (ROA)
10.25%
TTM Avg
8.68%
3Y Avg
8.17%
5Y Avg
8.38%
Market Cap
$1.81B
Return on Assets (ROA)
-6.55%
TTM Avg
-5.28%
3Y Avg
-5.65%
5Y Avg
-2.06%
Market Cap
$1.83B
Return on Assets (ROA)
-4.29%
TTM Avg
-7.68%
3Y Avg
-13.57%
5Y Avg
-14.36%
Market Cap
$1.83B
Return on Assets (ROA)
1.78%
TTM Avg
2.10%
3Y Avg
3.84%
5Y Avg
3.40%
Market Cap
$1.84B
Return on Assets (ROA)
-24.34%
TTM Avg
-44.90%
3Y Avg
-10.89%
5Y Avg
-12.22%
Market Cap
$1.77B
Return on Assets (ROA)
-61.53%
TTM Avg
-47.53%
3Y Avg
-47.53%
5Y Avg
-47.53%
Market Cap
$1.85B
Return on Assets (ROA)
-44.98%
TTM Avg
-76.52%
3Y Avg
-94.59%
5Y Avg
-76.85%
Market Cap
$1.75B
Return on Assets (ROA)
-1.10%
TTM Avg
-1.54%
3Y Avg
-1.02%
5Y Avg
-1.23%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Xencor, Inc. (XNCR) | $1.81B | -22.53% | -17.47% | -13.86% | -9.24% |
| LeMaitre Vascular, Inc. (LMAT)vs › | $1.81B | 10.25% | 8.68% | 8.17% | 8.38% |
| Azenta, Inc. (AZTA)vs › | $1.81B | -6.55% | -5.28% | -5.65% | -2.06% |
| Sarepta Therapeutics, Inc. (SRPT)vs › | $1.83B | -4.29% | -7.68% | -13.57% | -14.36% |
| Astrana Health, Inc. (ASTH)vs › | $1.83B | 1.78% | 2.10% | 3.84% | 3.40% |
| Palvella Therapeutics, Inc. (PVLA)vs › | $1.84B | -24.34% | -44.90% | -10.89% | -12.22% |
| Generate Biomedicines, Inc. (GENB)vs › | $1.77B | -61.53% | -47.53% | -47.53% | -47.53% |
| Immunome, Inc. (IMNM)vs › | $1.85B | -44.98% | -76.52% | -94.59% | -76.85% |
| Surgery Partners, Inc. (SGRY)vs › | $1.75B | -1.10% | -1.54% | -1.02% | -1.23% |
| Novavax, Inc. (NVAX)vs › | $1.86B | -25.92% | 12.70% | -8.51% | -21.36% |
ROA
-22.5%
ROE
-32.5%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -10.50% |
| 2024-12-31 | -24.44% |
| 2023-12-31 | -13.97% |
| 2022-12-31 | -6.52% |
| 2021-12-31 | 9.86% |
| 2020-12-31 | -9.86% |
| 2019-12-31 | 4.01% |
| 2018-12-31 | -12.21% |
| 2017-12-31 | -12.54% |
| 2016-12-31 | 5.51% |
| 2015-12-31 | -8.50% |
| 2014-12-31 | -24.21% |
| 2013-12-31 | -69.01% |
| 2012-12-31 | -73.71% |
| 2011-12-31 | -50.07% |
